Gripil Pharmaceuticals Private Limited, a active private limited company, was established on 23 July 2009 in Vasai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100MH2009PTC194336. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.20 M.
It upholds a compliant status. Employing 11 professional, Its leadership includes Aarti Chandan Soni (Director), Chandan Rajgopal Soni (Director). Past directors included Jaswantrai Jagjivandas Mehta. It holds ₹21.85 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 2, Ground Flr, Nagasai Apt., Chandansar, Virar, Vasai, Maharashtra, 401303.
U24100MH2009PTC194336
194336
23 July 2009
₹5.00 M
₹1.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Gripil Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aarti Chandan Soni | Director | 23 Jul 2009 | Current |
| Chandan Rajgopal Soni | Director | 23 Jul 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gripil Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.24% increase. The company also saw a substantial improvement in profitability, with a 65.66% increase in profit. The company's net worth moved up by a moderate rise of 5.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Gripil Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹218,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Bank Of India | ₹20.00 Cr | Open |
| 01 Mar 2023 | Hdfc Bank Limited | ₹7.50 M | Open |
| 21 Oct 2015 | The Saraswat Co-Op Bank Ltd | ₹1.00 M | Open |
| 25 Feb 2010 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Gripil Pharmaceuticals has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gripil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gripil Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gripil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Gripil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Bank Of India amounted to Rs. 200.00 M with Charge ID 100911552 was registered on 26 Mar 2024. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 7.50 M with Charge ID 100694266 was registered on 01 Mar 2023. was completed.
The activity A charge with Others of Rs. 10.00 M registered on 25 Feb 2010 with Charge ID 10206359 was modified on 24 Jul 2020. was completed.
A charge with The Saraswat Co-Op Bank Ltd amounted to Rs. 1.00 M with Charge ID 10599466 was registered on 21 Oct 2015. was recorded as a recent event.
The CIN of Gripil Pharmaceuticals Private Limited is U24100MH2009PTC194336.
Gripil Pharmaceuticals Private Limited is headquartered at Flat No. 2, Ground Flr, Nagasai Apt., Chandansar, Virar, Vasai, Maharashtra, 401303.
Gripil Pharmaceuticals Private Limited was incorporated on 23 July 2009.
The current directors of Gripil Pharmaceuticals Private Limited are
The primary industry of Gripil Pharmaceuticals Private Limited is Manufacturing.
Gripil Pharmaceuticals Private Limited is unlisted.
The authorized capital of Gripil Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹1.20 M.
The compliance status of Gripil Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX